Author:
Ivins B E,Ezzell J W,Jemski J,Hedlund K W,Ristroph J D,Leppla S H
Abstract
Live, attenuated strains of Bacillus anthracis lacking either the capsule plasmid pXO2, the toxin plasmid pXO1, or both were tested for their efficacy as vaccines against intravenous challenge with anthrax toxin in Fischer 344 rats and against aerosol or intramuscular challenge with virulent anthrax spores in Hartley guinea pigs. Animals immunized with toxigenic, nonencapsulated (pXO1+, pXO2-) strains survived toxin and spore challenge and demonstrated postimmunization antibody titers to the three components of anthrax toxin (protective antigen, lethal factor, and edema factor). Immunization with two nontoxigenic, encapsulated (pXO1-, pXO2+), Pasteur vaccine strains neither provided protection nor elicited titers to any of the toxin components. Therefore, to immunize successfully against anthrax toxin or spore challenge, attenuated, live strains of B. anthracis must produce the toxin components specified by the pXO1 plasmid.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference30 articles.
1. Rapid lethal effect in rats of a third component found upon fractionating the toxins of Bacillus anthracis;Beall F. A.;J. Bacteriol.,1961
2. Field evaluation of a human anthrax vaccine;Brachman P. S.;Am. J. Public Health,1962
3. Colton T. 1974. Statistics in medicine p. 30-31. Little Brown and Co. Boston.
4. Immunological studies of anthrax. I. An index to determine quantitative immunization;DeArmon I. A.;J. Immunol.,1961
5. Descour L. 1923. Attenuation and reinforcement of a virus p. 187-189. In Pasteur and his work 2nd ed. T. Fisher Unwin Ltd. London. (Translated from French by A. F. Webb and B. H. Webb.)
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献